Condition: Air Pollution · Atherosclerosis · Sponsor: University of Southern California
This double-blind, randomized, crossover trial aims to test the hypothesis that longer-term indoor air filtration intervention can slow atherothrombosis progression by reducing indoor fine particulate matter (PM2.5) exposure in adults with ischemic heart disease history.
This description comes directly from the study's public registry record.
Zhanghua Chen, PhD · 323-442-2109 · zhanghuc@usc.edu
Junfeng Zhang, PhD · 919-681-7782 · junfeng.zhang@duke.edu
Always discuss trial participation with your own doctor first.
| Keck School of Medicine, University of Southern California | Los Angeles, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05867381